Ming Xi

545 total citations
25 papers, 364 citations indexed

About

Ming Xi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming Xi has authored 25 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming Xi's work include Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (6 papers) and RNA Research and Splicing (5 papers). Ming Xi is often cited by papers focused on Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (6 papers) and RNA Research and Splicing (5 papers). Ming Xi collaborates with scholars based in China, Macao and United States. Ming Xi's co-authors include Yi Xiao, Jiaying Wu, Yueping Wan, Weide Zhong, Wei Hua, Yulin Zhou, Yuanling Liu, Wan Song, Jinhuan Xu and Di Wang and has published in prestigious journals such as Nature, Journal of Ethnopharmacology and Cancer Letters.

In The Last Decade

Ming Xi

24 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming Xi China	11	257	224	48	34	31	25	364
Amy Ho Hong Kong	10	294 1.1×	252 1.1×	47 1.0×	34 1.0×	20 0.6×	12	434
Duncan Hughes United States	5	287 1.1×	275 1.2×	39 0.8×	77 2.3×	32 1.0×	6	441
Jianning Zhao China	11	282 1.1×	261 1.2×	26 0.5×	16 0.5×	13 0.4×	13	375
Zhenhuan Ma China	9	186 0.7×	128 0.6×	32 0.7×	26 0.8×	9 0.3×	19	286
Qingchuan Dong China	7	212 0.8×	185 0.8×	34 0.7×	28 0.8×	8 0.3×	11	344
Jian Fang China	12	295 1.1×	216 1.0×	62 1.3×	61 1.8×	10 0.3×	25	432
Yuming Gu China	10	280 1.1×	202 0.9×	29 0.6×	37 1.1×	8 0.3×	33	453
Qiandong Zhu China	10	212 0.8×	168 0.8×	45 0.9×	40 1.2×	7 0.2×	14	309
Laura Pietrovito Italy	9	206 0.8×	172 0.8×	65 1.4×	34 1.0×	25 0.8×	13	361

Countries citing papers authored by Ming Xi

Since Specialization

Citations

This map shows the geographic impact of Ming Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Xi more than expected).

Fields of papers citing papers by Ming Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Xi. The network helps show where Ming Xi may publish in the future.

Co-authorship network of co-authors of Ming Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Xi. A scholar is included among the top collaborators of Ming Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Xi. Ming Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lv, Xinyu, et al.. (2025). Cold atmospheric plasma targets triple negative breast cancer cells via SCAF11-mediated competitive protein degradation and synergizes with miRNA-146b-5p. International Journal of Biological Macromolecules. 312. 144142–144142.

Dai, Xiaofeng, Xiaoli Hui, & Ming Xi. (2025). Critical factors driving diabetic retinopathy pathogenesis and a promising interventional strategy. Biomedicine & Pharmacotherapy. 189. 118106–118106. 3 indexed citations

Dai, Xiaofeng, Ming Xi, & Jitian Li. (2025). Cancer metastasis: molecular mechanisms and therapeutic interventions. Molecular Biomedicine. 6(1). 20–20. 3 indexed citations

Jiang, Lin, et al.. (2025). [Advances in pathogenesis of asthma airway remodeling and intervention mechanism of traditional Chinese medicine].. PubMed. 50(8). 2050–2070. 1 indexed citations

Pan, Wei, Li Wen, Dengji Pan, et al.. (2025). Temperature-related hospitalization burden under climate change. Nature. 644(8078). 960–968. 5 indexed citations

Dai, Xiaofeng, et al.. (2025). Cold atmospheric plasma potentiates ferroptosis via EGFR(Y1068)-mediated dual axes on GPX4 among triple negative breast cancer cells. International Journal of Biological Sciences. 21(2). 874–892. 8 indexed citations

Zou, Zhihao, Zhengrong Zhang, Huichan He, et al.. (2024). Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC. Cancer Letters. 605. 217286–217286. 5 indexed citations

Xi, Ming, et al.. (2024). Xuanhong Dingchuan Tang suppresses bronchial asthma inflammation via the microRNA-107-3p/PTGS2/MAPK axis. Functional & Integrative Genomics. 25(1). 1–1. 3 indexed citations

Huang, Feng, Xiaoyun Tong, Chunyan Hu, et al.. (2023). CAVO Inhibits Airway Inflammation and ILC2s in OVA‐Induced Murine Asthma Mice. BioMed Research International. 2023(1). 8783078–8783078. 1 indexed citations

10.

Tong, Xiaoyun, Qiushi Zhang, Xiaohong Li, et al.. (2023). Baiheqingjin formula reduces inflammation in mice with asthma by inhibiting the PI3K/AKT/NF-κb signaling pathway. Journal of Ethnopharmacology. 321. 117565–117565. 12 indexed citations

11.

Gong, Xia, Wei Wang, Lei Zhang, et al.. (2022). Association of retinal fractal dimension and vessel tortuosity with impaired renal function among healthy Chinese adults. Frontiers in Medicine. 9. 925756–925756. 2 indexed citations

12.

Huang, Lifang, et al.. (2022). CircNFIX knockdown inhibited AML tumorigenicity by the miR-876-3p/TRIM31 axis. Hematology. 27(1). 1046–1055. 10 indexed citations

13.

Shang, Zhen, Ming Xi, Jiaying Wu, & Yi Xiao. (2021). Downregulation of circ_0012152 inhibits proliferation and induces apoptosis in acute myeloid leukemia cells through the miR‐625‐5p/SOX12 axis. Hematological Oncology. 39(4). 539–548. 21 indexed citations

14.

Cai, Zhiduan, Yangjia Zhuo, Ming Xi, et al.. (2020). Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer. BMC Cancer. 20(1). 289–289. 9 indexed citations

15.

Xiao, Yi, Ming Xi, & Jiaying Wu. (2020). Hsa_circ_0002483 regulates miR‐758‐3p/MYC axis to promote acute myeloid leukemia progression. Hematological Oncology. 39(2). 243–253. 20 indexed citations

16.

Song, Wan, Ming Xi, Haibo Zhao, et al.. (2019). HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer. Pathology - Research and Practice. 215(8). 152464–152464. 25 indexed citations

17.

Wan, Yueping, Ming Xi, Huichan He, et al.. (2017). Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer. Oncology Research and Treatment. 40(1-2). 15–20. 20 indexed citations

18.

Zhuo, Yangjia, Ming Xi, Yueping Wan, et al.. (2015). Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer. International Journal of Molecular Medicine. 35(4). 966–972. 32 indexed citations

19.

Xi, Ming, Lü Cheng, Yueping Wan, & Wei Hua. (2015). [Incidence of depression and its related factors in cryptorchidism patients after surgical treatment].. PubMed. 21(1). 57–60. 3 indexed citations

20.

Wan, Yueping, Ming Xi, Wan Song, et al.. (2014). Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer. Human Pathology. 46(2). 295–303. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact